- Review
- Open access
- Published:
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review
Harm Reduction Journal volume 21, Article number: 150 (2024)
Abstract
Purpose
Fueled by the prescription opioid overdose crisis and increased influx of illicitly manufactured fentanyl, fentanyl overdoses continue to be a public health crisis that has cost the US economy over $1 trillion in reduced productivity, health care, family assistance, criminal justice, and accounted for over 74,000 deaths in 2023. A recent demographic shift in the opioid crisis has led to a rise in overdose deaths among the Latinx population. Harm reduction interventions, including the use of naloxone and fentanyl test strips, have been shown to be effective measures at reducing the number of opioid overdose deaths. The aim of this scoping review is to summarize naloxone and fentanyl test strip interventions and public health policies targeted to Latinx communities.
Methods
PubMed, CINHAL, Web of Science, Embase, and PsycINFO research databases using the keywords “fentanyl,” “Latinx,” “Harm Reduction,” “Naloxone,” and “Fentanyl Test Strips'' to identify studies published between January 1, 2013 and December 31, 2023. Endnote and Covidence software were used to catalog and manage citations for review of studies. Subsequently, studies that met inclusion criteria were then summarized using resulting themes.
Results
Twenty-seven articles met the inclusion criteria and were further abstracted for the scoping review. Of these articles, 77.7% (n = 21) included a naloxone intervention, while only 11.1% (n = 3) included a fentanyl test strip intervention. Furthermore, 30.1% (n = 8) of these studies were Latinx targeted, and 7.7% (n = 2) of the studies were adapted for Latinx populations. Four themes, including an overall lack of knowledge and awareness, a lack of access to harm reduction or opioid overdose prevention resources, an overall lack of culturally adapted and/or targeted interventions, and restrictive and punitive policies that limit the effectiveness of protective factors were highlighted in this scoping review.
Conclusion
Limited published research exists on the use of emerging harm reduction behaviors, such as the use of naloxone and fentanyl test strips as community intervention strategies to prevent opioid overdose deaths. Even fewer publications exist on the targeting and cultural adaptation of harm reduction interventions responsive to Latinx communities, especially those using theoretical approaches or frameworks to support these interventions. Future research is needed to assess the unique needs of Latinx populations and to develop culturally responsive programs to prevent opioid-related overdose deaths among this population.
Introduction
Over the last decade, fentanyl overdoses in the United States have climbed to staggering proportions. In 2021, more people between the ages of 15–54 died from an opioid-related overdose than from COVID-19 [1]. In 2022, fentanyl, also known as “Dance Fever,” “Dragon’s Breath,” or “Tango and Cash,” resulted in the deaths of over 100,000 individuals in the United States [2]. The loss of life resulting from fentanyl and its analogs has reached such a devastating level that fentanyl-related overdoses have been propelled into a public health emergency and garnered prominence on the national political stage [3,4,5]. In the United States, the Drug Enforcement Agency (DEA) classifies fentanyl as a schedule II narcotic under the United States Controlled Substances Act of 1970. This classification is reserved for drugs that are considered high risk for both physical and psychological dependence and have a high capacity for both use disorder and misuse [6]. Due to the increased influx of illicitly manufactured fentanyl, the DEA has also identified China and Mexico as significant producers of illicitly manufactured fentanyl found in the United States [7,8,9]. As the opioid crisis in the United States continues, the need for increasing the effectiveness of overdose interventions, such as naloxone and fentanyl test strips (FTS) distribution and educational interventions will become critical in curtailing the effects of illicitly manufactured fentanyl.
Nationally, more than ten million people over the age of 12 are estimated to have engaged in opioid misuse over the past year [10,11,12,13]. Of these, over two million of those who misused opioids identify as Latinx/Hispanic (Here, Latinx is used as a gender-neutral term for self-identifying Latin individuals [13]. Overall, opioid overdose deaths have steadily increased throughout the nation, with the death rates among the Latinx population doubling between 1999 and 2017 [14, 15]. More specifically, the greatest increase in opioid-related deaths among this population is due to synthetic opioids, most notably fentanyl. Fentanyl is the most commonly involved opioid in unintentional overdose deaths among the Latinx population at 40.2% [16]. These fentanyl-related opioid overdose deaths have increased 617% over the past ten years [16].
Naloxone and FTS are considered effective overdose prevention interventions, resulting in their widespread use in public health and social service programs in states with supportive policies [13, 17]. Indeed, public health policies that aim to strengthen data collection, safer prescribing practices, stigma and harm reduction, treatment expansion, and criminal justice reform are critical areas of the public health spectrum that may serve to improve the effectiveness of interventions involving naloxone and FTS [18]. While policies such as Naloxone Access Laws, Naloxone Standing Orders, and Good Samaritan Laws have been developed and enacted to increase access to Naloxone and offer legal protection to bystanders who intervene in an overdose situation, not all states have enacted these harm reduction policies [19]. Harm reduction policies are currently composed of one or a combination of three major policies. These policies are Naloxone Access Laws, Naloxone Standing Order Laws, and Good Samaritan Laws. Naloxone Access Laws provide legal immunity provisions for individuals who prescribe, dispense, or administer naloxone [20]. Naloxone Standing Order Statutes authorize pharmacists to dispense naloxone under a standing prescription, eliminating the need for a patient-prescriber encounter [21]. Lastly, Good Samaritan Laws provide legal protection to bystanders in the event that they may need to intervene in an overdose incident. The purpose of this approach is to encourage people to help those experiencing an overdose without fear of legal liability [22]. While these statutes aim to expand access to naloxone and offer legal protections, some states, such as Texas, have yet to enact the Naloxone Standing Order or Good Samaritan statutes [23]. Limiting protections for and access to Latinx communities further decreases the likelihood of successfully reducing fentanyl-related overdose rates, especially among minority populations. Furthermore, as of 2020, all states have enacted Naloxone Access laws. However, only 33 states enacted Naloxone Access, Naloxone Standing Order, and Good Samaritan laws. Conversely, two states, Texas and Wyoming, have enacted only Naloxone Access Laws.
Understanding the planning, implementation, and evaluation of opioid-related harm reduction interventions responsive to the unique needs of the Latinx/Hispanic population in the United States is an area of emerging priority. The Latinx population is experiencing a time of significant population growth in the United States [24]. The US Latinx community grew to over 62.5 million people in 2021, representing a twenty-four percent increase in just eleven years [24]. This significant growth accounts for more than 52% of the population growth of the entire United States [24]. This population continues to face numerous health challenges due to a variety of structural, cultural, and social barriers to health services, as well as significant disparities in health outcomes ranging from HIV infections to type 2 diabetes, to opioid overdose deaths [25, 26]. These disparities are further exacerbated by social factors such as limited health insurance access and utilization, higher rates of medical distrust, and lower rates of medical adherence [27]. Cultural barriers to seeking care, including language barriers, legal status, stigma, and discrimination, are pervasive, significant, and impactful to these communities. Despite these barriers, there are opportunities for continued improvement in health outcomes due to facilitating and protective factors such as more positive attitudes and improving levels of trust towards health interventions [28,29,30,31,32].
Specifically related to opioid misuse, many fentanyl transportation routes traverse Latin America to the United States. This observation, in concert with cultural, economic, and social barriers, may contribute to an environment for the off-label use and sharing of both prescribed and illicit medications [16, 17]. These are only a few of the issues that result in the ongoing increases in unintentional opioid-related overdose deaths among Latinx populations [16]. As Latinx populations in the United States continue to grow, it is important to meet this population’s health and social needs.
Harm reduction strategies are proven to mitigate the number of unintentional opioid-related overdose deaths [33]. The harm reduction approach acknowledges abstinence as the ideal outcome but takes a person-centered strategy that seeks to mitigate risks through the provision of safer choice options [34]. Harm reduction approaches to mitigate the impact of opioid misuse and its associated health effects can include but are not limited to, the use of naloxone and the use of FTS [17, 35,36,37]. It is estimated that approximately 70% of unintentional opioid overdose deaths could be avoided through known harm reduction strategies [13]. Therefore, with the sharp increase in opioid-related deaths among Latinx populations, more understanding is needed to assess the viability of the implementation of harm reduction strategies and supportive policies for this at-risk population [13]. To this end, a literature review was conducted to describe interventions and policies used with Latinx populations.
Methods
Five established research databases (PubMed, Embase, PsycINFO, CINAHL, Web of Science) were used to search and compile available publications. The established inclusion criteria for the review were studies published between January 1, 2013 and December 31, 2023, studies published in the English language, and studies based in the United States or its territories. Both qualitative and quantitative studies that met the inclusion criteria were included for review. The scoping review was conducted utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines [38]. The University of Texas at Austin and University of Nevada, Reno library portals allowed for the electronic search of the databases for analysis. The search included a range of terms, including text words and amended vocabulary words, to elicit maximum results. The search terms included Latin*, Hispanic, fentanyl, naloxone, fentanyl overdose, fentanyl test strips, community readiness, overdose prevention, community readiness, opioid harm reduction, harm reduction, education, and outreach. These terms were combined with Boolean operators such as AND and OR for additional results.
Planned searches were queried using independent and sequential searches of the established strategy. The results were gathered as Research Information System (.ris) files, and these files were subsequently imported into the Covidence software system (Melbourne, Australia) for title, abstract screening, full-text screening, and data extraction. Covidence software was used to eliminate duplicate articles gathered from queries. Upon deduplication in Covidence, amended files were also imported into the Zotero or Endnote reference management software for ease of gathering full texts of included studies that were not automatically uploaded into Covidence and to create memos and notes of the reviewed articles.
Five established criteria were used to determine inclusion in the scoping review: (1) discussion of harm reduction strategies, such as distribution of naloxone or use of FTS; (2) inclusion of Latinx/Hispanic populations in the study; (3) health context of opioid use/misuse; (4) study published in English; (5) study occurred in the United States or its territories. Articles were excluded if they did not explicitly mention opioids or include reference to Latinx/Hispanic populations. A study must have met all five inclusion criteria in order for it to be considered for review.
Screening of titles and abstracts of de-duplicated results were conducted independently for each article by two authors (GL and GD) with initial discussion on operational definitions and inclusion criteria established prior to coding. Articles meeting initial screening criteria were moved to the second stage of full-text screening prior to data extraction. Any article accepted from the initial title and abstract screening from either coder (GL and GD) was included for a full-text screening. Following a full-text screening by the two authors, independent decisions by each author were discussed during a meeting that included the further refinement of operational definitions and inclusion criteria. Initial matched decisions after full-text review were moved into the data extraction phase. Those articles with unmatched decisions were discussed and reconciliation of coding decisions was established through a reassessment of the inclusion criteria. Resolved matches that met inclusion criteria were also moved to the data extraction phase. The authors took detailed notes of discussions and decision-making throughout the process.
Additional quality assessment was ensured through inter-rater reliability (IRR) calculations of the percentage of agreement and Cohen’s kappa prior to unmatched decision reconciliation and data extraction. The percentage of agreement was calculated at 97.3% (393/404), showing strong levels of agreement. As an additional measurement of reliability, Cohen’s kappa was calculated to assess the degree of IRR between the two coders that also account for chance. The Cohen’s kappa coefficient was calculated with a value of 0.761, indicating a substantial level of agreement.
A standard data extraction template was created using Covidence for those articles that met the abstract and full-text review phases of analysis. Within the data extraction template, several fields were collected, including (1) article details (authors, year of publication, title, journal); (2) study details (aim, study design, participant/sample characteristics); (3) Latinx/Hispanic details, such as percentage/total number of Latinx/Hispanic participants; whether the research was “Latinx/Hispanic targeted” which was defined as resources specifically designed to address the needs of Latinx and Hispanic communities who are disproportionately affected by fentanyl overdoses and/or “Latinx/Hispanic intervention adapted” that was defined as existing evidence-based interventions that were modified to better suit the needs and cultural context of the Latinx and Hispanic communities; (4) intervention characteristics (phase in intervention: coded as planning/assessment, implementation, or evaluation; type of intervention: coded as Narcan/naloxone and/or FTS or neither; theory/framework utilized: open-ended or coded as NA if none were applied); (6) study results (outcomes, recommendations, limitations). Using axial and open coding techniques, an iterative process was used to establish and stratify themes of outcomes and recommendations listed within the studies.
Results
The screening was conducted in a four-stage process using a documented search strategy (Fig. 1). The scoping review yielded a total of 823 studies that were imported for screening (Fig. 2). In stage 1 of the review process, 419 duplicates were identified by Covidence and were removed from further analysis, leaving 404 studies for review. In stage 2, 404 studies were screened through an abstract review process by the authors (GL and GD), matching the study abstracts to the inclusion criteria. Any studies that were unclear in meeting inclusion criteria were also included for full-text review to determine inclusion. In total, 337 studies were excluded from the stage 2 evaluation process review. In stage 3, 48 studies were subject to a full-text review. Twenty-one of the studies were excluded after a full-text review due to having an intervention or study design that did not meet the inclusion criteria. In total, 27 studies from 11 states and Puerto Rico were included for data abstraction (Fig. 3).
All 27 studies were empirical and met the inclusion criteria for data abstraction. Of the 27 studies, 73% (n = 19) explicitly included Narcan/naloxone, such as prescribed naloxone interventions, community-distributed interventions, peer-distributed interventions, or take-home naloxone interventions. Conversely, only 11.5% (n = 3) of studies focused on fentanyl test strip strategies that included both fentanyl strip interventions or a discussion of fentanyl test strips and drug checking services (DCS) more broadly. These results highlight the apparent underutilization of FTS compared to the more reactive interventions involving Narcan/naloxone among Latinx communities. A total of 30.1% (n = 8) of these studies explicitly studied or targeted the Latinx/Hispanic population through oversampling, researching an area with a large Latinx/Hispanic demographic, or including racial/ethnic comparisons with adequate sample sizes. Finally, 7.7% (n = 2) of the studies were adapted interventions for Latinx populations where the interventions included cultural adaptation, language adaptation, or the study design focused on assessments unique to the Latinx/Hispanic community (Table 1).
When considering the phase of intervention in the lifecycle, 53.8% (n = 14) of the studies existed in the planning and assessment phase, which sometimes included a discussion of lived experiences with harm reduction interventions or an assessment of attitudes, norms, or beliefs related to harm reduction or opioid use in general. 19.2% (n = 5) of the included studies were in the intervention implementation phase, often through a pilot study or a description of a program enacted. Finally, 26.9% (n = 7) of the studies existed in the evaluation phase of the intervention lifecycle, which included an assessment of outcomes or program effectiveness.
In total, 11.5% (n = 3) of studies included some reference to a theory, framework, or behavior change model. One study was grounded in social networks theory [10]. Another used the information-motivation-behavior skills model of behavior change [11]. The third proposed a new theoretical framework of “unmet obligations” that was situated at the intersection of structural injustice, policy change, and critical race understandings [10, 11, 39].
Thematic analysis
Based on the analysis, four themes emerged from the studies: (1) an overall lack of knowledge and awareness of opioid use in general, Narcan/naloxone, FTS, and/or harm reduction strategies; (2) an overall lack of access to harm reduction or opioid overdose prevention resources; (3) an overall lack of culturally adapted and/or targeted interventions; (4) restrictive and punitive policies that limit protective factors (Table 2).
The most prominent theme was that many members of the Latinx/Hispanic community are unaware of interventions, such as naloxone to prevent opioid overdose deaths, fentanyl test kits to test drugs, or harm reduction strategies in general [40]. Despite lower levels of health literacy related to harm reduction and opioid overdose awareness among all populations, Latinx audiences often demonstrated the least amount of knowledge [17]. The studies clearly showed a lack of outreach to Latinx communities for community education efforts [17].
Latinx individuals also had less access to harm reduction or opioid prevention resources when compared to White, non-Hispanics [41, 42]. Although closely related to a lack of knowledge and awareness, Latinx individuals were less likely to be prescribed naloxone by a medical provider [43, 44] and are also less likely to have access to drug-checking services and FTS than their White, non-Hispanic counterparts [37, 45]. When having access to opioid overdose prevention resources, Latinx populations had greater odds of using the naloxone they bring home [28, 46,47,48] and were more likely to refill the prescription for naloxone [49, 50]. Finally, after a known fentanyl exposure, Latinx community members are more likely to adopt harm-reduction behaviors [51].
Another theme that emerged is an overall lack of culturally responsive education and intervention programs specifically targeted to Latinx communities. Although interventions exist, the lack of cultural adaptation prevents their overall uptake [52, 53]. Latinx communities are responsive to harm reduction strategies adapted to their culture and language and have shown a willingness to receive education and resources in various formats, including virtually or through the utilization of community health workers [49, 54,55,56]. However, cultural factors, experiences, restrictive policies, including the war on drugs, and drug paraphernalia laws, impede the inability to distribute naloxone or FTS legally, restrictions on pharmacist-led standing orders on naloxone, and restrictions on peer-based naloxone distribution, further marginalize Latinx communities (Fig. 4). Due to interactions with immigration, discrimination, or stigma, Latinx communities can be more cautious in adopting opioid overdose prevention strategies when residing in communities with restrictive policies [28, 36, 54, 56,57,58].
Punitive and restrictive policies related to naloxone and FTS was also a prominent theme throughout this scoping review. Indeed, in Pennsylvania, a lack of supportive policies showed that Latinos were shown to be more likely to be arrested in cases where naloxone was administered compared to Whites and Blacks [59]. Harm reduction studies also advocated for policy changes to allow for increasing the ease of access to naloxone, FTS, and other drug-checking services [36, 56]. In order to advance overdose prevention interventions, one study suggested increasing the inclusion of Black and Latinx individuals in positions of policy leadership to better meet the needs of diverse populations [58]. While major legislative policies aim to increase ease of access to harm reduction strategies, additional work is needed to improve upon the underutilization of these interventions.
Discussion
This scoping review displays the ongoing need for the planning, assessment, implementation, and evaluation of key opioid overdose prevention strategies such as naloxone distribution and the widespread use of FTS, especially among Latinx populations. Overall, the results indicate that more education and outreach are needed on harm reduction strategies, especially strategies that provide choice, options, and innovative solutions. Expanding education efforts related to harm reduction policies among Latinx communities about naloxone and FTS distribution sites, use, and legal protections may present areas of opportunity to increase the utilization of harm reduction measures among the Latinx population. The scoping review highlights a few innovative interventions, such as virtual, culturally responsive training and peer outreach through the use of trained community health workers [43, 54]. Latinx individuals are more open to harm reduction interventions than non-Hispanic Whites but less likely to receive the opioid overdose prevention resources they need to protect themselves and their communities [36, 43].
The needs and resources of the Latinx community present a unique opportunity for intervention. While sources of naloxone distribution encompass a wide array of sites such as emergency departments [60, 61], syringe service programs [62], pharmacies [63], community peer-based interventions [64], opioid agonist treatment services, among others, these distribution methods often lack a cultural framework amenable to acceptance with the Latinx community. Additionally, the distribution of rapid FTS in these settings may provide an added measure of protection, as FTS has been shown to be a more acceptable form of harm reduction, especially among young adults [65, 66]. Culturally, barriers such as cultural norms to buy medication outside of a medical setting or to share medications can put Latinx community members at undue risk of potential opioid overdose death [17]. Socially, restrictive policies preventing access to harm reduction resources, coupled with structural and systemic barriers of past discrimination and stigma within the healthcare system and among law enforcement, created an ongoing threat to optimal health and safety [35, 36, 56]. Restrictive and punitive policy implications may result in limiting the utilization of evidence-based harm reduction measures, increasing fentanyl-related overdose deaths, or increasing stigma, leading at-risk individuals away from seeking help, especially among Latinx individuals. Punitive policies that classify drug checking material, such as FTS, as paraphernalia may serve to further deter members of the Latinx community from utilizing these harm reduction measures. Indeed, efforts in many states’ legislative bodies are underway to remove FTS from being classified as drug paraphernalia. Currently, 32 states still consider “testing equipment for the use in identifying, or in analyzing the strength, effectiveness or purity of controlled substances'' as drug paraphernalia and are therefore outlawed [19].
Yet, culturally relevant opportunities for change also exist, including core Latinx norms of a collectivist culture, a focus on the family, and extended social networks that can serve as protective factors associated with increased use of opioid overdose prevention resources and decreased deaths among this population [10, 47, 55]. More targeted, culturally responsive, and adapted interventions are needed that directly meet the needs of Latinx populations. Examples of such interventions may include increasing language accessibility, incorporating family-centered approaches, religious or spiritual integration, or reducing stigma. Overall, the scoping review elucidated the need for additional interventions in all stages of the intervention lifecycle that are grounded in proven theories and frameworks that may be increasingly impactful to Latinx populations in reducing unintentional opioid overdose deaths.
Conclusion
While reactive interventions involving naloxone continue to expand overall, prophylactic measures such as FTS remain underutilized among Latinx communities. Increasing awareness and access while addressing barriers to accessing FTS may contribute to reducing the number of unintentional fentanyl-related overdose deaths. The Latinx population may also be subjected to additional barriers in accessing FTS. These may include a lack of knowledge, fear of deportation, language barriers, cultural stigma, and financial considerations [17]. Furthermore, many Latinx individuals are unaware of the existence of FTS or do not know how to use them. This may be particularly relevant in rural areas or communities with historically limited access to healthcare resources. Surprisingly, researchers have highlighted a paradoxical phenomenon among Latinx communities, indicating that Latinx individuals may be protected from the prescription opioid crisis as a result of their inability to access care, but this observation does not appear to confer protective effects with respect to obtaining illegal drugs [67].
This scoping review of opioid overdose prevention interventions to promote the use of naloxone and FTS highlights the willingness of Latinx community members to adopt harm reduction strategies. However, limited opportunities for education, outreach, and the provision of resources are available. Interventions that are culturally adapted and responsive are limited, lack theoretical foundations, and are not implemented at scale. Although threats related to the cultural norms of the Latinx community exist, there are also unique opportunities to build upon these cultural norms that can serve as protective factors to achieve optimal health. Moreover, this scoping review highlights the need for future research in the development, implementation, and evaluation of evidence-based, culturally responsive programs to meet the needs of Latinx populations in combating opioid overdose deaths within their communities.
Availability of data and materials
No datasets were generated or analysed during the current study.
References
Volkow ND, Califf RM, Sokolowska M, Tabak LA, Compton WM. Testing for fentanyl - urgent need for practice-relevant and public health research. N Engl J Med. 2023;388(24):2214–7.
Kariisa M, O’Donnell J, Kumar S, Mattson CL, Goldberger BA. Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine - United States, January 2019-June 2022. MMWR Morb Mortal Wkly Rep. 2023;72(26):721–7.
O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and u-47700 - 10 states, July-december 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–202.
Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013–2014. MMWR Morb Mortal Wkly Rep. 2016;65(33):837–43.
Dai Z, Abate MA, Smith GS, Kraner JC, Mock AR. Fentanyl and fentanyl-analog involvement in drug-related deaths. Drug Alcohol Depend. 2019;196:1–8.
Preuss CV, Kalava A, King KC. Prescription of controlled substances: benefits and risks. Treasure Island, FL: StatPearls; 2024.
Wang C, Lassi N, Zhang X, Sharma V. The evolving regulatory landscape for fentanyl: China, India, and global drug governance. Int J Environ Res Public Health. 2022. https://doi.org/10.3390/ijerph19042074.
Friedman J, Hansen H, Bluthenthal RN, Harawa N, Jordan A, Beletsky L. Growing racial/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California. Prev Med. 2021;153: 106845.
Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, et al. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019;200:59–63.
Bennett AS, Scheidell J, Bowles JM, Khan M, Roth A, Hoff L, et al. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City. Harm Reduct J. 2022;19(1):20.
Coffin PO, Santos GM, Matheson T, Behar E, Rowe C, Rubin T, et al. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: a pilot randomized controlled trial. PLoS ONE. 2017;12(10): e0183354.
López CI, Richards DK, Field CA. Perceived discrimination and alcohol-related problems among Hispanic college students: the protective role of serious harm reduction behaviors. J Ethn Subst Abuse. 2022;21(1):272–83.
Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA Opioid Overdose Prevention Toolkit. Rockville, MD: 2018 Contract No.: HHS Publication No. (SMA) 18-4742. https://ldh.la.gov/assets/docs/BehavioralHealth/SAMHSA_Opioid_Overdose_Prevention_Toolkit_revised_2018.pdf.
Valdez A, Cepeda A, Frankeberger J, Nowotny KM. The opioid epidemic among the Latino population in California. Drug Alcohol Depend Rep. 2022;2: 100029.
Cano M. Drug overdose deaths among us hispanics: trends (2000–2017) and recent patterns. Subst Use Misuse. 2020;55(13):2138–47.
Substance Abuse and Mental Health Services Administration (SAMHSA). The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue. 2020 Contract No.: Publication No. PEP20-05-02-002. https://store.samhsa.gov/sites/default/files/pep20-05-02-002.pdf.
Unger JB, Molina GB, Baron MF. Opioid knowledge and perceptions among Hispanic/Latino residents in Los Angeles. Subst Abus. 2021;42(4):603–9.
Saloner B, McGinty EE, Beletsky L, Bluthenthal R, Beyrer C, Botticelli M, et al. A public health strategy for the opioid crisis. Public Health Rep. 2018;133(1_Suppl):24s–34s.
Legislative Analysis and Public Policy Association. Fentanyl Test Strips. 2021. https://legislativeanalysis.org/wp-content/uploads/2021/05/Fentanyl-Teststrips-FINAL-1.pdf.
Smart R, Pardo B, Davis CS. Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. Addiction. 2021;116(1):6–17.
Gravlee E, Ramachandran S, Cafer A, Holmes E, McGregor J, Jordan T, et al. Naloxone accessibility under the state standing order across mississippi. JAMA Netw Open. 2023;6(7): e2321939.
Atkins DN, Durrance CP, Kim Y. Good Samaritan harm reduction policy and drug overdose deaths. Health Serv Res. 2019;54(2):407–16.
United States Census Bureau. U.S. Census Bureau QuickFacts: Texas. Census Bureau QuickFacts. n.d. Available from: https://www.census.gov/quickfacts/fact/table/TX/RHI725222#RHI725222.
Krogstad JM, Passel JS, Moslimani M, Noe-Bustamante L. Key facts about U.S. Latinos for National Hispanic Heritage Month. Pew Research Center. 2023.
Pinedo M, Zemore S, Rogers S. Understanding barriers to specialty substance abuse treatment among Latinos. J Subst Abuse Treat. 2018;94:1–8.
Aguayo-Mazzucato C, Diaque P, Hernandez S, Rosas S, Kostic A, Caballero AE. Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States. Diabetes Metab Res Rev. 2019;35(2): e3097.
Chen Y, Ngo V, Park SY. Caring for caregivers: designing for integrality. In: Proceedings of the 2013 conference on computer supported cooperative work; San Antonio, Texas, USA: Association for Computing Machinery; 2013; pp. 91–102.
Katzman JG, Takeda MY, Greenberg N, Moya Balasch M, Alchbli A, Katzman WG, et al. Association of take-home naloxone and opioid overdose reversals performed by patients in an opioid treatment program. JAMA Netw Open. 2020;3(2): e200117.
Heo M, Beachler T, Sivaraj LB, Tsai HL, Chea A, Patel A, et al. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community. Subst Abuse Treat Prev Policy. 2023;18(1):23.
Lee Y-H, Woods C, Shelley M, Arndt S, Liu C-T, Chang Y-C. Racial and ethnic disparities and prevalence in prescription drug misuse, illicit drug use, and combination of both behaviors in the united states. Int J Mental Health Addict. 2023. https://doi.org/10.1007/s11469-023-01084-0.
Fogel J, Adnan M. Trust for online social media direct-to-consumer prescription medication advertisements. Health Policy Technol. 2019;8(4):322–8.
Delorme DE, Huh J, Reid LN. Evaluation, use, and usefulness of prescription drug information sources among Anglo and Hispanic Americans. J Health Commun. 2010;15(1):18–38.
Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):3.
Marlatt GA. Harm reduction: come as you are. Addict Behav. 1996;21(6):779–88.
Gazzola MG, Hayman C, Stansky D, Genes N, Wittman I, Doran KM, et al. Emergency department fentanyl test strip distribution in a large urban health system. Acad Emerg Med. 2023;30:161.
Bailey K, Abramovitz D, Artamonova I, Davidson P, Stamos-Buesig T, Vera CF, et al. Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego. California Int J Drug Policy. 2023;118: 104086.
Abdelal R, Raja Banerjee A, Carlberg-Racich S, Darwaza N, Ito D, Shoaff J, et al. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders. Harm Reduct J. 2022. https://doi.org/10.1186/s12954-022-00627-3.
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.
Lopez AM, Thomann M, Dhatt Z, Ferrera J, Al-Nassir M, Ambrose M, et al. Understanding racial inequities in the implementation of harm reduction initiatives. Am J Public Health. 2022;112(S2):S173–81.
Boeri M, Lamonica AK. Naloxone perspectives from people who use opioids: findings from an ethnographic study in three states. J Am Assoc Nurse Pract. 2020;33(4):294–303.
Nolen S, Trinidad AJ, Jordan AE, Green TC, Jalali A, Murphy SM, et al. Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City. Res Sq. 2023;68(1):967.
Rosales R, Janssen T, Yermash J, Yap KR, Ball EL, Hartzler B, et al. Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19. J Subst Abuse Treat. 2022;132: 108648.
Madden EF, Qeadan F. Racial inequities in U.S naloxone prescriptions. Subst Abus. 2020;41(2):232–44.
Kinnard EN, Bluthenthal RN, Kral AH, Wenger LD, Lambdin BH. The naloxone delivery cascade: identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA. Drug Alcohol Depend. 2021;225: 108759.
Tilhou AS, Birstler J, Baltes A, Salisbury-Afshar E, Malicki J, Chen G, et al. Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin. Harm Reduct J. 2022;19(1):142.
Weiner SG, Carroll AD, Brisbon NM, Rodriguez CP, Covahey C, Stringfellow EJ, et al. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose. J Subst Abuse Treat. 2022;139:1–6.
Katzman JG, Greenberg NH, Takeda MY, Moya BM. Characteristics of patients with opioid use disorder associated with performing overdose reversals in the community: an opioid treatment program analysis. J Addict Med. 2019;13(2):131–8.
Dwyer K, Walley AY, Langlois BK, Mitchell PM, Nelson KP, Cromwell J, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381–4.
Madden EF, Qeadan F. Racial inequities in U.S. naloxone prescriptions. Subst Abuse. 2020;41(2):232–44.
Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015;110(8):1301–10.
Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Harm Reduct J. 2019;16(1):39.
Chatterjee A, Yan S, Xuan Z, Waye KM, Lambert AM, Green TC, et al. Broadening access to naloxone: community predictors of standing order naloxone distribution in Massachusetts. Drug Alcohol Depend. 2022;230: 109190.
Ashford RD, Curtis B, Brown AM. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program. Harm Reduct J. 2018;15(1):52.
Gandara E, Recto P, Zapata J, Moreno-Vasquez A, Idar AZ, Castilla M, et al. Reducing opioid use disorder health inequities within Latino communities in South Texas. Public Health Nurs. 2023;40(1):163–6.
Bagley SM, Forman LS, Ruiz S, Cranston K, Walley AY. Expanding access to naloxone for family members: the Massachusetts experience. Drug Alcohol Rev. 2018;37(4):480–6.
Abadie R. “I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies. Harm Reduct J. 2023;20(1):75.
Mathias CW, Cavazos DM, McGlothen-Bell K, Crawford AD, Flowers-Joseph B, Wang Z, et al. Opioid overdose prevention education in Texas during the COVID-19 pandemic. Harm Reduct J. 2023;20(1):37.
Khan MR, Hoff L, Elliott L, Scheidell JD, Pamplin JR 2nd, Townsend TN, et al. Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City. Harm Reduct J. 2023;20(1):24.
Barboza GE, Angulski K. A descriptive study of racial and ethnic differences of drug overdoses and naloxone administration in Pennsylvania. Int J Drug Policy. 2020;78: 102718.
Wagner KD, Oman RF, Smith KP, Harding RW, Dawkins AD, Lu M, et al. “Another tool for the tool box? I’ll take it!”: feasibility and acceptability of mobile recovery outreach teams (MROT) for opioid overdose patients in the emergency room. J Subst Abuse Treat. 2020;108:95–103.
Sindhwani MK, Friedman A, O’Donnell M, Stader D, Weiner SG. Naloxone distribution programs in the emergency department: a scoping review of the literature. J Am Coll Emerg Physicians Open. 2024;5(3): e13180.
Patel SV, Wenger LD, Kral AH, Sherr K, Wagner AD, Davidson PJ, et al. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the systems analysis and improvement approach within syringe service programs. BMC Health Serv Res. 2023;23(1):278.
Egan KL, Foster SE, Knudsen AN, Lee JGL. Naloxone availability in retail pharmacies and neighborhood inequities in access. Am J Prev Med. 2020;58(5):699–702.
Naumann RB, Durrance CP, Ranapurwala SI, Austin AE, Proescholdbell S, Childs R, et al. Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug Alcohol Depend. 2019;204: 107536.
Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52–8.
Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7.
Brenes F, Henriquez F. Hispanics, addictions, and the opioid epidemic: brief report. Hisp Health Care Int. 2020;18(1):40–3.
Author information
Authors and Affiliations
Contributions
GL designed the study, conducted data extraction, analysis, review and wrote the manscript. GD conducted data extraction, analysis, and review. JU reviewed and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no that they have competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Luna, G., Dermid, G. & Unger, J.B. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review. Harm Reduct J 21, 150 (2024). https://doi.org/10.1186/s12954-024-01070-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12954-024-01070-2